{"id":"W2764336049","doi":"10.1093/annonc/mdx371.073","title":"Pembrolizumab ± chemotherapy versus chemotherapy in advanced urothelial cancer: Phase 3 KEYNOTE-361 trial","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Moncton Hospital","funders":"","keywords":"Medicine; Urothelial cancer; Pembrolizumab; Chemotherapy; Oncology; Internal medicine; Cancer; Bladder cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001402756,0.001332604,0.002668194,0.0002862923,0.0004575961,0.00115873,0.0009877105,0.001387303,0.007919678],"category_scores_gemma":[0.001284928,0.0005162866,0.002513665,0.0003800724,0.0008259007,0.001297459,0.0004988303,0.005290297,0.001326562],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001424911,"about_ca_system_score_gemma":0.001498188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001397226,"about_ca_topic_score_gemma":0.00376949,"domain_scores_codex":[0.9996067,0.0001829506,0.00001871951,0.00008834815,0.00002201375,0.00008128339],"domain_scores_gemma":[0.9993506,0.0001615227,0.0001381423,0.00004764768,0.00002604702,0.0002759771],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9268534,0.006991233,0.0005316476,0.001604698,0.001937612,0.00005908728,0.00008856873,0.001882845,0.004499207,0.0004094974,0.005172938,0.04996915],"study_design_scores_gemma":[0.9026868,0.0897281,0.002124178,0.0001127051,0.0009874433,0.00007508069,0.00003334139,0.0006616713,0.0006335613,0.0005253337,0.002412288,0.00001946905],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9662665,0.01491901,0.0008954721,0.003478648,0.0009570608,0.002782778,0.003484662,0.0002769209,0.006938886],"genre_scores_gemma":[0.975192,0.00713171,0.001833164,0.002945104,0.0004885636,0.002746859,0.002726399,0.00006731226,0.006868945],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007919678,"threshold_uncertainty_score":0.02649391,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1276922113237782,"score_gpt":0.4850912875659827,"score_spread":0.3573990762422046,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}